BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26666150)

  • 1. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.
    Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Rossing K; Hansen TW; Rossing P
    Diabetes Care; 2014 Jun; 37(6):1660-7. PubMed ID: 24623028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study.
    Gunzler D; Bleyer AJ; Thomas RL; O'Brien A; Russell GB; Sattar A; Iyengar SK; Thomas C; Sedor JR; Schelling JR
    BMC Nephrol; 2013 Jun; 14():124. PubMed ID: 23773264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
    Sasso FC; Chiodini P; Carbonara O; De Nicola L; Conte G; Salvatore T; Nasti R; Marfella R; Gallo C; Signoriello S; Torella R; Minutolo R;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel diagnostic and therapeutic procedures in diabetic nephropathy].
    Pont'uch P
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S57-62. PubMed ID: 27124974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
    Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification of Diabetic Nephropathy 2014].
    Haneda M; Utsunomiya K; Koya D; Babazono T; Moriya T; Makino H; Kimura K; Suzuki Y; Wada T; Ogawa S; Inaba M; Kanno Y; Shigematsu T; Masakane I; Tsuchiya K; Honda K; Ichikawa K; Shide K; ; ; ; ;
    Nihon Jinzo Gakkai Shi; 2014; 56(5):547-52. PubMed ID: 25130030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and old markers of progression of diabetic nephropathy.
    Jerums G; Premaratne E; Panagiotopoulos S; Clarke S; Power DA; MacIsaac RJ
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S30-7. PubMed ID: 18937992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does body mass index influence the decline of glomerular filtration rate in diabetic type 2 patients with diabetic nephropathy in a developing country?
    Bentata Y; Latrech H; Abouqal R
    Ren Fail; 2014 Jul; 36(6):838-46. PubMed ID: 24673339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
    Folan LA; Tuttle KR
    Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
    Molitch ME; Adler AI; Flyvbjerg A; Nelson RG; So WY; Wanner C; Kasiske BL; Wheeler DC; de Zeeuw D; Mogensen CE
    Kidney Int; 2015 Jan; 87(1):20-30. PubMed ID: 24786708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and treatment of diabetic nephropathy.
    Woredekal Y
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():999-1004. PubMed ID: 18806717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.